Chlorogiannis D, Moussa A, Zhao K, Alexander E, Sofocleous C, Sotirchos V
Diagnostics (Basel). 2024; 14(7).
PMID: 38611685
PMC: 11011364.
DOI: 10.3390/diagnostics14070772.
Katharina Ingenerf M, Karim H, Fink N, Ilhan H, Ricke J, Treitl K
Acta Radiol. 2021; 63(7):877-888.
PMID: 34225464
PMC: 9194807.
DOI: 10.1177/02841851211024004.
Maas M, Beets-Tan R, Gaubert J, Munoz F, Habert P, Klompenhouwer L
Insights Imaging. 2020; 11(1):83.
PMID: 32676924
PMC: 7366866.
DOI: 10.1186/s13244-020-00884-5.
Willowson K, Hayes A, Chan D, Tapner M, Bernard E, Maher R
EJNMMI Res. 2017; 7(1):46.
PMID: 28536968
PMC: 5442040.
DOI: 10.1186/s13550-017-0292-1.
Dendy M, Ludwig J, Kim H
Oncotarget. 2017; 8(23):37912-37922.
PMID: 28415671
PMC: 5514961.
DOI: 10.18632/oncotarget.16007.
F-FDG PET/CT predicts survival after Y transarterial radioembolization in unresectable hepatocellular carcinoma.
Jreige M, Mitsakis P, Van Der Gucht A, Pomoni A, Silva-Monteiro M, Gnesin S
Eur J Nucl Med Mol Imaging. 2017; 44(7):1215-1222.
PMID: 28233086
DOI: 10.1007/s00259-017-3653-0.
The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases.
Pieper C, Meyer C, Sprinkart A, Block W, Ahmadzadehfar H, Schild H
Onco Targets Ther. 2016; 9:4089-98.
PMID: 27462163
PMC: 4940017.
DOI: 10.2147/OTT.S104770.
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
Shady W, Sotirchos V, Do R, Pandit-Taskar N, Carrasquillo J, Gonen M
AJR Am J Roentgenol. 2016; 207(3):661-70.
PMID: 27384594
PMC: 5675077.
DOI: 10.2214/AJR.15.15202.
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
Shady W, Kishore S, Gavane S, Do R, Osborne J, Ulaner G
Eur J Radiol. 2016; 85(6):1224-31.
PMID: 27161074
PMC: 5675072.
DOI: 10.1016/j.ejrad.2016.03.029.
Selective Internal Radiation Therapy in Metastatic Carcinoma of the Colon: A Story of Nonintegrated Care?.
Buscombe J
World J Nucl Med. 2016; 15(2):79-80.
PMID: 27134555
PMC: 4809158.
DOI: 10.4103/1450-1147.178010.
Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single....
Pieper C, Sprinkart A, Meyer C, Konig R, Schild H, Kukuk G
Medicine (Baltimore). 2016; 95(14):e3275.
PMID: 27057887
PMC: 4998803.
DOI: 10.1097/MD.0000000000003275.
Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases.
Kennedy A, Ball D, Cohen S, Cohn M, Coldwell D, Drooz A
J Gastrointest Oncol. 2015; 6(6):594-604.
PMID: 26697190
PMC: 4671850.
DOI: 10.3978/j.issn.2078-6891.2015.082.
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.
Sofocleous C, Violari E, Sotirchos V, Shady W, Gonen M, Pandit-Taskar N
Clin Colorectal Cancer. 2015; 14(4):296-305.
PMID: 26277696
PMC: 5058358.
DOI: 10.1016/j.clcc.2015.06.003.
Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
Barabasch A, Kraemer N, Ciritsis A, Hansen N, Lierfeld M, Heinzel A
Invest Radiol. 2015; 50(6):409-15.
PMID: 25763526
PMC: 4420152.
DOI: 10.1097/RLI.0000000000000144.
Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer.
Sabet A, Meyer C, Aouf A, Sabet A, Ghamari S, Pieper C
Eur J Nucl Med Mol Imaging. 2014; 42(3):370-6.
PMID: 25351506
DOI: 10.1007/s00259-014-2935-z.
Yttrium-90 radioembolization of hepatic metastases from colorectal cancer.
Raval M, Bande D, Pillai A, Blaszkowsky L, Ganguli S, Beg M
Front Oncol. 2014; 4:120.
PMID: 25120951
PMC: 4110696.
DOI: 10.3389/fonc.2014.00120.
Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers.
Nowicki M, Cwikla J, Sankowski A, Shcherbinin S, Grimmes J, Celler A
Med Sci Monit. 2014; 20:1353-62.
PMID: 25086245
PMC: 4136939.
DOI: 10.12659/MSM.890480.
The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.
Annunziata S, Treglia G, Caldarella C, Galiandro F
ScientificWorldJournal. 2014; 2014:879469.
PMID: 24672385
PMC: 3929576.
DOI: 10.1155/2014/879469.
Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.
Eldredge-Hindy H, Ohri N, Anne P, Eschelman D, Gonsalves C, Intenzo C
Am J Clin Oncol. 2014; 39(2):189-95.
PMID: 24441583
PMC: 4101073.
DOI: 10.1097/COC.0000000000000033.
Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol.
Akhlaghpoor S, Aziz-Ahari A, Amoui M, Tolooee S, Poorbeigi H, Sheybani S
World J Gastroenterol. 2012; 18(37):5249-59.
PMID: 23066320
PMC: 3468858.
DOI: 10.3748/wjg.v18.i37.5249.